• Latest Posts

As J&J Vaccine Fails Phase II, the Quest for an HIV Vaccine Continues

HIV Drug Approvals Lift Hopes Amid Missed UN Targets

ViiV Healthcare’s Monthly HIV Injection Gains First Approval in Canada

Update: Cancer Immunotherapy Biotech Files for Insolvency

ViiV Healthcare Licenses Long-Acting Antibody to Attack Hidden HIV

Two-Drug HIV Therapy Given Every 2 Months Proves Effective in Phase III


HIV Drug Suppresses Virus for Almost Two Years When Other Treatments Fail

EU Approves Two-Drug Pill as First-Line Treatment for HIV

Startup Scout 14 Jun 2019

This Biotech Reduces Drug Side Effects Using Silica Gel Implants

Interview 12 Jun 2019

How Vaccines Could One Day Beat HIV

‘CRISPR Babies’ Might Be at Risk of Dying Younger

Update: Two-Drug HIV Treatment Effective for up to Three Years